We are live on ! Find out more
BBA

BLB&B Advisors Portfolio holdings

AUM $2.73B Turnover 8.25%
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$1.23B
AUM Growth
+$240M
Cap. Flow
+$111M
Cap. Flow %
9.02%
Top 10 Hldgs %
36.82%
Holding
276
New
34
Increased
121
Reduced
91
Closed
10
Avg Time Held
4.9 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
3.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.19%
2 Technology 12.37%
3 Healthcare 9.55%
4 Financials 7.04%
5 Consumer Staples 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JCI icon
151
Johnson Controls International
JCI
$92.3B
$693K 0.06%
14,872
-6,024
-29% -$268K
2013 Q2
30 quarters
MDY icon
152
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.3B
$680K 0.06%
1,620
-80
-5% -$30.8K
2013 Q2
30 quarters
HSY icon
153
Hershey
HSY
$33B
$666K 0.05%
4,375
-100
-2% -$14.8K
2013 Q4
28 quarters
SWK icon
154
Stanley Black & Decker
SWK
$13.6B
$654K 0.05%
3,665
-221
-6% -$39.2K
2013 Q2
30 quarters
SO icon
155
Southern Company
SO
$103B
$647K 0.05%
10,536
-1,171
-10% -$70.4K
2013 Q2
30 quarters
EXC icon
156
Exelon
EXC
$43.9B
$646K 0.05%
21,438
+5,452
+34% +$161K
2013 Q2
30 quarters
IWB icon
157
iShares Russell 1000 ETF
IWB
$49B
$641K 0.05%
3,027
– –
2020 Q3
1 quarter
EMN icon
158
Eastman Chemical
EMN
$7.19B
$622K 0.05%
6,200
-1,375
-18% -$127K
2013 Q2
30 quarters
UL icon
159
Unilever
UL
$138B
$589K 0.05%
+8,680
New +$589K
2020 Q4
0 quarters
PM icon
160
Philip Morris
PM
$320B
$576K 0.05%
6,954
+4,120
+145% +$321K
2020 Q3
1 quarter
ORCL icon
161
Oracle
ORCL
$396B
$564K 0.05%
8,725
+2,500
+40% +$149K
2013 Q2
30 quarters
PEG icon
162
Public Service Enterprise Group
PEG
$35.2B
$554K 0.04%
9,507
+2,533
+36% +$147K
2013 Q4
28 quarters
TMO icon
163
Thermo Fisher Scientific
TMO
$249B
$551K 0.04%
1,182
-58
-5% -$27.2K
2016 Q1
19 quarters
MO icon
164
Altria Group
MO
$122B
$549K 0.04%
13,398
+2,860
+27% +$115K
2013 Q2
30 quarters
EW icon
165
Edwards Lifesciences
EW
$49.8B
$536K 0.04%
5,880
+720
+14% +$59.7K
2016 Q2
18 quarters
MUB icon
166
iShares National Muni Bond ETF
MUB
$48.8B
$531K 0.04%
4,527
– –
2016 Q1
19 quarters
NOC icon
167
Northrop Grumman
NOC
$70.4B
$531K 0.04%
1,743
+607
+53% +$186K
2017 Q3
13 quarters
CTVA icon
168
Corteva
CTVA
$8.94B
$516K 0.04%
13,330
-692
-5% -$24.7K
2019 Q2
6 quarters
SBUX icon
169
Starbucks
SBUX
$106B
$515K 0.04%
4,816
+1,290
+37% +$123K
2019 Q1
7 quarters
SRPT icon
170
Sarepta Therapeutics
SRPT
$1.78B
$511K 0.04%
+3,000
New +$445K
2020 Q4
0 quarters
MS icon
171
Morgan Stanley
MS
$285B
$486K 0.04%
7,094
+2,034
+40% +$117K
2020 Q2
2 quarters
ET icon
172
Energy Transfer Partners
ET
$69.7B
$483K 0.04%
78,177
+14,017
+22% +$84.8K
2020 Q1
3 quarters
HPQ icon
173
HP
HPQ
$27.5B
$482K 0.04%
19,595
-2,076
-10% -$43.6K
2015 Q4
20 quarters
VXUS icon
174
Vanguard Total International Stock ETF
VXUS
$161B
$478K 0.04%
7,941
+573
+8% +$32.2K
2020 Q2
2 quarters
IGSB icon
175
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$473K 0.04%
8,570
-200
-2% -$11K
2013 Q3
29 quarters

Similar funds

BLB&B Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, BLB&B Advisors held 276 positions worth $1.23B, up 24% from $995M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

BLB&B Advisors deployed $111M of net new capital in Q4 2020, opening 34 new positions and adding to 121 existing holdings. Its largest new stake was Schwab US Large-Cap Growth ETF: 104,304 shares worth $1.67M.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 42% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.76M trimmed.

  • BLB&B Advisors's largest Q4 2020 buy was Schwab US Large-Cap Growth ETF: 104,304 shares worth $1.67M.
  • BLB&B Advisors added most to Vanguard FTSE Developed Markets ETF in Q4 2020, an estimated $11M increase.
  • BLB&B Advisors's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.76M.
  • BLB&B Advisors fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $513K.
  • BLB&B Advisors's ten largest holdings make up 37% of its $1.23B portfolio in Q4 2020.
  • BLB&B Advisors opened 34 new positions and closed 10 in Q4 2020.
  • BLB&B Advisors's portfolio value rose 24% quarter-over-quarter to $1.23B.

Based on BLB&B Advisors's 13F filing for Q4 2020, filed 19 Jan 2021.